Citation Impact
Citing Papers
A Comparison of Rate Control and Rhythm Control in Patients with Atrial Fibrillation
2002 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage in Adults
2007
Bacterial Community Variation in Human Body Habitats Across Space and Time
2009 StandoutScience
The X-ray crystal structure of the membrane protein prostaglandin H2 synthase-1
1994 StandoutNature
Diagnostic efficacy of the D-Dimer assay in disseminated intravascular coagulation (DIC)
1992
Pharmacology and Management of the Vitamin K Antagonists
2008 Standout
Omega‐6/Omega‐3 Fatty Acid Ratio and Trans Fatty Acids in Non‐Insulin‐dependent Diabetes Mellitus
1997
Evidence-Based Management of Anticoagulant Therapy
2012
The Effect of Dietary Supplementation with n—3 Polyunsaturated Fatty Acids on the Synthesis of Interleukin-1 and Tumor Necrosis Factor by Mononuclear Cells
1989 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Costs and Clinical Outcomes Associated With Low-Molecular-Weight Heparin vs Unfractionated Heparin for Perioperative Bridging in Patients Receiving Long-term Oral Anticoagulant Therapy
2004
A Clinical Trial of the Effects of Dietary Patterns on Blood Pressure
1997 Standout
Oral Anticoagulant Therapy
2012 Standout
Omega-3 fatty acids in health and disease and in growth and development
1991 Standout
Prognosis and Management after a First Myocardial Infarction
1990
Recognition of specific sialoglycan structures by oral streptococci impacts the severity of endocardial infection
2019
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
2003
Phylogeny of the Serpin Superfamily: Implications of Patterns of Amino Acid Conservation for Structure and Function
2000
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Systemic lupus erythematosus
2001
An evidence‐based review and guidelines for patient self‐testing and management of oral anticoagulation
2005
Angiogenesis in cancer and other diseases
2000 StandoutNature
The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome
1995 Standout
Twelve‐month outcomes and predictors of very stable INR control in prevalent warfarin users
2010
Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus
2003 Standout
Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
1997
Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
1993 StandoutNobel
Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism
2009 Standout
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Platelet Activation and Atherothrombosis
2007 Standout
p38 Mitogen-activated Protein Kinase Phosphorylates Cytosolic Phospholipase A2 (cPLA2) in Thrombin-stimulated Platelets
1996
DIABETIC NEUROPATHY
1998
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
The Use of Aspirin in Ischemic Heart Disease
1992
The Antiphospholipid Syndrome
2002 Standout
Dietary supplementation with omega-3 polyunsaturated fatty acids in patients with stable coronary heart disease
1988
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation
2001
Effects of dietary fish oil on platelet function and plasma lipids in hyperlipoproteinemic and normal subjects
1988
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
2008 Standout
External quality assessment (EQA) for CoaguChek monitors
2010
Triglyceride lowering effect of MaxEPA fish lipid concentrate: A multicentre placebo controlled double blind study
1988
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Systematic Overview of Warfarin and Its Drug and Food Interactions
2005 Standout
Role of prothrombin complex concentrates in reversing warfarin anticoagulation: A review of the literature
2007
Vascular-Bed–Specific Hemostasis and Hypercoagulable States
1999
Inhibition of atherosclerosis by fish oil in cholesterol-fed rabbits
1988
Disseminated Intravascular Coagulation
1999 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Warfarin for atrial fibrillation in community‐based practise
2008
Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty
1989
Prophylaxis of Atherosclerosis with Marine Omega-3 Fatty Acids
1987
Treatment of Traumatic Brain Injury with Moderate Hypothermia
1997 Standout
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
1988 Standout
Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease
2011 StandoutNature
The importance of the ratio of omega-6/omega-3 essential fatty acids
2002 Standout
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
2005 Standout
Hypertonic Induction of Aquaporin-5 Expression through an ERK-dependent Pathway
2000 StandoutNobel
A Prospective Study of Moderate Alcohol Consumption and the Risk of Coronary Disease and Stroke in Women
1988 Standout
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
Prevention of Polymerization of M and Z α 1 -Antitrypsin ( α 1 -AT) with Trimethylamine N -Oxide
2001
Degradation of phosphatidylinositol-4,5-bisphosphate is insensitive to Ca2+ mobilization in stimulated platelets
1982
Polyamine inhibition of gastric ulceration and secretion in rats
1983
Role of endothelium in responses of vascular smooth muscle.
1983 StandoutNobel
Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid
1986
Leukocyte lipid body formation and eicosanoid generation: cyclooxygenase-independent inhibition by aspirin.
1996 StandoutNobel
In Vivo Indexes of Platelet and Vascular Function during Fish-Oil Administration in Patients with Atherosclerosis
1986
Effect of a moderate fish intake on blood pressure, bleeding time, hematology, and clinical chemistry in healthy males
1987
Release of Prostaglandins and Thromboxane into the Coronary Circulation in Patients with Ischemic Heart Disease
1981
Ethanol inhibits platelet thromboxane A2 production but has no effect on lung prostacyclin synthesis in humans
1984
Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence
1986 Standout
Nonenzymatic Glycosylation and the Pathogenesis of Diabetic Complications
1984
Lysosomal cathepsin D mediates endogenous mucin glycodomain catabolism in mammals
2022 StandoutNobel
Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
1976 StandoutNobel
HUMAN ARTERIAL AND VENOUS TISSUES GENERATE PROSTACYCLIN (PROSTAGLANDIN X), A POTENT INHIBITOR OF PLATELET AGGREGATION
1977 StandoutNobel
Enhancing effect of dietary supplementation with ω-3 fatty acids on plasma fibrinolysis in normal subjects
1985
Linolenate-derived Polyunsaturated Fatty Acids and Prevention of Atherosclerosis
2009
Dietary Fats and Blood Pressure
1994
Sorbitol, Phosphoinositides, and Sodium-Potassium-ATPase in the Pathogenesis of Diabetic Complications
1987 Standout
Aspirin and Other Platelet-Active Drugs
1992
Renal actions of prostacyclin
1978 StandoutNatureNobel
Outcomes and predictors of very stable INR control during chronic anticoagulation therapy
2009
Metabolism and effects on platelet function of the purified eicosapentaenoic and docosahexaenoic acids in humans.
1985
Thromboxane A2in Vasotonic Angina Pectoris
1981
Defining the Normal Bacterial Flora of the Oral Cavity
2005 Standout
Localisation and stimulation of prostacyclin production in vascular cells
1978 Nature
Analysis of prostacyclin and thromboxane biosynthesis in cardiovascular disease.
1983
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet Activation
1984
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
1983
Spermidine in health and disease
2018 StandoutScience
Hypothermia-induced reduction in the permeation of radiolabelled tracer substances across the blood-brain barrier
1983
Dose-Related Kinetics of Aspirin
1984
Multifocal fiber loss in proximal sciatic nerve in symmetric distal diabetic neuropathy
1982
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Effects of a fish oil supplement on platelet function, haemostatic variables and albuminuria in insulin-dependent diabetics
1986
Genetic Relationships between Clinical Isolates of Streptococcus pneumoniae , Streptococcus oralis , and Streptococcus mitis : Characterization of “Atypical” Pneumococci and Organisms Allied to S. mitis Harboring S. pneumoniae Virulence Factor-Encoding Genes
2000
Flow Effects on Prostacyclin Production by Cultured Human Endothelial Cells
1985 Science
Diabetes as an atherogenic factor
1984
Clinical pharmacology of platelet cyclooxygenase inhibition.
1985
DIFFERENTIAL INHIBITION BY LOW-DOSE ASPIRIN OF HUMAN VENOUS PROSTACYCLIN SYNTHESIS AND PLATELET THROMBOXANE SYNTHESIS
1981
Effects of a fish oil supplement on serum lipids, blood pressure, bleeding time, haemostatic and rheological variables
1987
Fish Consumption and Cardiovascular Mortality in Canada: An Inter-Regional Comparison
1988
Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin
1985 StandoutNature
Prostaglandins and Thromboxanes
1978 StandoutNobel
Role of Adenosine 3′,5′-Monophosphate in the Effects of Insulin and Anti-insulin Serum on Liver Metabolism
1968 StandoutNobel
Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls
1979 StandoutNobel
Paradoxical Vasoconstriction Induced by Acetylcholine in Atherosclerotic Coronary Arteries
1986 Standout
Effect of the stable endoperoxide analog U-46619 on prostacyclin production and cyclic AMP levels in bovine endothelial cells
1984
Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy Subjects
1982 Standout
Triglyceride-lowering effect of marine polyunsaturates in patients with hypertriglyceridemia.
1985
STUDIES ON EXPERIMENTAL DIABETES. 3. EFFECTS OF ACUTE INSULIN INSUFFICIENCY ON 14C-GLUCOSE FORMATION FROM LABELED SUBSTRATES.
1964
Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets.
1990
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
Effects of intravenous prostacyclin in variant angina.
1982
Markedly Reduced Expression of Platelet c-mpl Receptor in Essential Thrombocythemia
1997
Works of F. E. Preston being referenced
Guidelines on oral anticoagulation: third edition
1998
Guidelines on testing for the lupus anticoagulant. Lupus Anticoagulant Working Party on behalf of the BCSH Haemostasis and Thrombosis Task Force.
1991
Beneficial effect of fish oil on blood viscosity in peripheral vascular disease.
1984
Thrombocytosis, circulating platelet aggregates, and neurological dysfunction.
1979
A placebo-controlled, double- blind study of eicosapentaenoic acid-rich fish oil in patients with stable angina pectoris
1990
Identity of viridans streptococci isolated from cases of infective endocarditis
1993
Elevated von Willebrand factor antigen predicts deterioration in diabetic peripheral nerve function
1996
Clinical Annotation. THE HYPERCOAGULABLE STATE IN CLINICAL PRACTICE
1991
Effects of dietary fish oil supplementation on the fatty acid composition of the human platelet membrane: demonstration of selectivity in the incorporation of eicosapentaenoic acid into membrane phospholipid pools
1985
Antithrombins Wibble and Wobble (T85M/K): Archetypal Conformational Diseases With In Vivo Latent-Transition, Thrombosis, and Heparin Activation
1998
Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets
1977 Nature
Genetic analysis, phenotypic diagnosis, and risk of venous thrombosis in families with inherited deficiencies of protein S
2000
Effects of epoxymethano analogues of prostaglandin endoperoxides on aggregation, on release of 5-hydroxytryptamine and on the metabolism of 3′,5′-cyclic AMP and cyclic GMP in human platelets
1979
Point-of-care International Normalised Ratios: UK NEQAS experience demonstrates necessity for proficiency testing of three different monitors
2006
Clinical and histological studies in diabetic neuropathy
1976
PLATELET ABNORMALITIES IN DIABETIC PERIPHERAL NEUROPATHY
1975
The effects of dietary ω-3 polyunsaturated fatty acids on erythrocyte membrane phospholipids, erythrocyte deformability and blood viscosity in healthy volunteers
1985
Characterization of Serum Fibrinogen and Fibrin Fragments Produced during Disseminated Intravascular Coagulation
1978
The effect of beta‐adrenoceptor antagonists on the pharmacokinetics and pharmacodynamics of warfarin.
1984
Failure of hyperthermia to open rat blood-brain barrier: Reduced permeation of sucrose
1982
Plasma 6-keto-prostaglandin F1α: Fact or fiction
1982
Inhibition of Prostacyclin and Platelet Thromboxane A2after Low-Dose Aspirin
1981
ELEVATED β-THROMBOGLOBULIN LEVELS AND CIRCULATING PLATELET AGGREGATES IN DIABETIC MICROANGIOPATHY
1978
Antithrombins Wibble and Wobble (T85M/K): Archetypal Conformational Diseases With In Vivo Latent-Transition, Thrombosis, and Heparin Activation
1998